US equities
|
INTC
$65.63
▼-28.72%
AMZN
$236.09
▼-3.16%
MU
$885.71
▼-5.20%
NVDA
$205.95
▼-3.61%
SNDK
$1,186.15
▼-10.82%
GOOGL
$279.93
▼-1.37%
AMD
$510.24
▼-9.92%
TSLA
$397.20
▼-1.51%
INTC
$65.63
▼-28.72%
AMZN
$236.09
▼-3.16%
MU
$885.71
▼-5.20%
NVDA
$205.95
▼-3.61%
SNDK
$1,186.15
▼-10.82%
GOOGL
$279.93
▼-1.37%
AMD
$510.24
▼-9.92%
TSLA
$397.20
▼-1.51%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Laverock Therapeutics
Laverock Therapeutics Reports Key Oncology Research Milestones
June 10, 2026
From
Laverock Therapeutics
Via
Business Wire
Laverock Therapeutics Awarded in Excess of £2.2M Through Two Innovation Grants to Support AI-powered Platform Development and to Expand Therapeutic Programmes Outside of Oncology
June 01, 2026
From
Laverock Therapeutics
Via
Business Wire